Fact CheckerSign in

NCT07143851Not yet recruiting

Multi-modal Intelligent Diagnosis System for Multiple Ophthalmic Diseases

Research on Key Technologies of Intelligent Auxiliary Diagnosis for Multiple Eye Diseases Based on Multimodal Ultra-High-Speed SS-OCT/OCTA

Source: ClinicalTrials.gov · Last updated 27 Aug 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

Aiming at the problems of low image reading efficiency, crowded medical resources and fragmented cross-modal information of ophthalmic OCT and OCTA, a multimodal large model diagnostic framework for various diseases such as retinal diseases and optic nerve damage in glaucoma is constructed to fully explore the complementary information of various images such as SS-OCT structural images, SS-OCTA vascular images and optic nerve scans. Extract cross-modal joint features to improve the accuracy of automatic diagnosis.

Status (registry)
Not yet recruiting
Study type
Observational
Enrollment
5000 (estimated)
First submitted
29 Jul 2025
Start date
30 Aug 2025
Primary completion date
30 Jun 2028
Lead sponsor
Beijing Hospital
Diseases
Glaucoma
NCT number
NCT07143851

What you commit to

  • Study type: Observational
  • Planned participants: 5000
  • From 30 Aug 2025 to the primary completion date, 30 Jun 2028
  • No sites listed in no country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • The image quality is poor and difficult to analyze due to reasons such as refractive media opacity and poor coordination.

Who the study is looking for

  • Diagnosed as macular degeneration, diabetic macular edema, retinal vein obstructive macular edema, high myopia, glaucoma or other clearly diagnosed ophthalmic diseases. The SS-OCT/SS-OCTA images of the patient are clear.

Age in the registry: 20 years to 90 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

This page is information, not medical advice. Discuss any trial with your doctor.